Virovet: Veterinarian comes on board
Belgian ViroVet NV, which develops vaccines and antiviral drug for livestock, has named George Gunn as the newest member of its board of directors. Until early 2015, Gunn was CEO of Novartis Animal Health and a member of the global executive committee of Novartis.
Before joining Novartis in 2003, he held various functions in the Animal Health Industry from head of Janssen Animal Health in the UK in 1996 up to president of Pharmacia Animal Health in the early 2000s. George Gunn is also on the board of Nextvet, Phibro Animal Health, Diversigen and Nuritas.
Gunn graduated with a bachelor of veterinary medicine and surgery from the Royal School of Veterinary Studies and received a diploma in veterinary state medicine from the same school five years later. In 2008, he received an honorary doctorate in veterinary medicine and surgery from the University of Edinburgh where he was appointed Regent.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium